About Us

SYNMEDIC Laboratories is one of the most innovative and progressive organizations, involved in manufacturing pharmaceutical formulations and bulk drugs with operations spanning various countries across the globe. The organization was conceived with the primary mission to provide quality healthcare to the ailing millions all over the world at an affordable cost, and this still remains the guiding force for us.

The company initially entered the pharma market with quality products in the vital healthcare segments such as Antibacterials, Analgesics/Antipyretics and Anti–inflammatory drugs. Greatly encouraged by the wide acceptance and positive market response, it expanded its product range to various other segments like Cardiology, Psychotropic, Neuro-Psychiatry, Endocrinology, Anti Tuberculosis, Anti M alarial, Gynecology, Gastroenterology and also bulk drugs. A complete range of Anti Retroviral products and latest molecules in Cephalosporins and Macrolides group of antibiotics constitute a large part of the company’s exports.

Today, SYNMEDIC is manufacturing and marketing over 150 branded and generic products in different strengths, growing exponentially in sales and market coverage ever since its inception. The market share of its formulations has grown remarkably because of the company’s strong and modern infrastructure, modern manufacturing facilities as well as robust systems that meet the most stringent international regulatory requirements, innovative marketing strategies, a sound financial base and above all, highly motivated manpower with expertise, skills and dedication in their respective fields of operation, which are continually enhanced through training.

Read more...
 

News

  • 1993

    Synmedic comes into existence and commences operations ...

     
  • 2000

    Synmedic attains Export House Status ...

     
  • 2002

    Unit I gets WHO GMP site certificate after joint inspection of facility, systems and documentation ...

     
  • June 2003

    Synmedic takes up massive formulation development work and goes into development of various modified release oral formulations and also numerous topical preparations as well as powders for oral suspension. ...

     
  • January 2005

    Construction of New plant (Unit II) Commences at Sector 31, Faridabad after exhaustive planning ...

     
  • June 2007

    Unit II becomes operational. Team of senior State Drugs Control officials from Haryana inspect the facility and grants manufacturing licence. Commends Team Synmedic for its efforts. ...

     
  • April 2008

    Unit II gets approval for Ukraine GMP after intensive inspection carried out by team from Ukraine Ministry of Health. ...

     
  • December 2010

    Renewal inspection successfully faced at Unit II for Ukraine GMP. ...

     
  • May 2011

    Successfully faced inspection for renewal of WHO GMP Site certificate. ...

     
  • March 2009

    WHO GMP site certificate obtained for Unit II after joint inspection by officials of CDSCO and Haryana State Drugs Control. ...

     
Turkish Online
.